Discovery of Diarylpyridine Derivatives As Novel Non-Nucleoside HIV-1 Reverse Transcriptase Inhibitors.

Xingtao Tian,Bingjie Qin,Hong Lu,Weihong Lai,Shibo Jiang,Kuo-Hsiung Lee,Chin Ho Chen,Lan Xie
DOI: https://doi.org/10.1016/j.bmcl.2009.07.080
2009-01-01
Abstract:Two series (4 and 5) of diarylpyridine derivatives were designed, synthesized, and evaluated for anti-HIV-1 activity. The most promising compound, 5e, inhibited HIV-1 IIIB, NL4-3, and RTMDR1 with low nanomolar EC50 values and selectivity indexes of >10,000. The results of this study indicate that diarylpyridine can be used as a novel scaffold to derive a new class of potent NNRTIs, active against both wild-type and drug-resistant HIV-1 strains.
What problem does this paper attempt to address?